Press Releases

 Filter by Provider

Leading fintech for financial institutions and the legal cannabis industry honored based on a comprehensive evaluation of workplace policies and employee experiences

Denver, Colorado--(Newsfile Corp. - May 13, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Landsea Homes Corporation (NASDAQ: LSEA) to New Home Co. for $11.30 per share in cash is fair to Landsea shareholders.

2261, Hazelwood Avenue, Gowrie, IA 50543 – PI Buy Sell Exchange has announced an update to its services for individuals seeking to exchange PI Coin, the digital currency associated with the PI Network. The platform has streamlined its processes to enhance the user experience and ensure efficient transaction handling for those looking to convert their holdings.

Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) (“Mogo” or the “Company”), a digital wealth and payments business, today announced that its portfolio company, WonderFi Technologies Inc. (TSX:WNDR) (“WonderFi”), has entered into a definitive agreement (the "Arrangement Agreement") with Robinhood Markets, Inc. (NASDAQ: HOOD) ("Robinhood") and a wholly owned subsidiary of Robinhood ("Purchaser"). Pursuant to the Arrangement Agreement, the Purchaser will acquire all of the issued and outstanding common shares of WonderFi ("Common Shares") for C$0.36 per Common Share by way of a statutory plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement").

Oragenics (NYSE American: OGEN) a biotechnology company developing intranasal therapies for brain-related disorders, announced it has received approval from Australia’s Human Research Ethics Committee (“HREC”) to begin a Phase II clinical trial of ONP-002, its proprietary neuroprotective therapy for mild traumatic brain injury (mTBI), or concussion. The clearance enables the company to initiate patient enrollment as early as Q2 2025 at Level 1 trauma emergency departments, where concussed patients are often treated. ONP-002, a non-invasive intranasal formulation, has demonstrated safety in Phase I and efficacy in preclinical models by reducing inflammation, oxidative stress and brain swelling. CEO Janet Huffman said the approval marks a key step toward expanding the ONP-002 program internationally, with enrollment sites also under consideration in New Zealand.

Champaign, Illinois--(Newsfile Corp. - May 13, 2025) - The Dr. Linus Anukwu Scholarship organization proudly announces the launch of its...

EQNX::TICKER_START (NASDAQ:CYCU),(NYSE:NET),(NASDAQ:PANW),(NASDAQ:AVGO),(NASDAQ:CRWD) EQNX::TICKER_END

The "Crypto Exchange Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering.

PALM BEACH, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Artificial Intelligence (Al) in cybersecurity market is rapidly expanding as organizations increasingly adopt Al-driven solutions to improve threat detection, prevention, and response to evolving cyber risks. The network security segment dominated the Al in cybersecurity market expansion in 2024 due to the critical need to safeguard organizational networks from evolving cyber threats. A report from an industry insider said that: “The global AI in cybersecurity market assessment, based on type, includes network security, endpoint security, application security, and cloud security. The network security segment dominated the AI in cybersecurity market expansion in 2024 due to the critical need to safeguard organizational networks from evolving cyber threats. Securing networks against malware, phishing, and ransomware attacks has become a top priority as enterprises increasingly adopt digital transformation initiatives and cloud-based infrastructures. AI-powered network security solutions excel in real-time traffic analysis, abnormality detection, and proactive threat mitigation, ensuring robust protection of sensitive data and operational continuity. This essential role in securing core systems and communications highlights the network security segment's dominance. The global AI in cybersecurity market evaluation, based on application, includes identity & access management, risk & compliance management, data loss prevention, unified threat management, fraud detection/ anti-fraud, threat intelligence, others. The data loss prevention segment is expected to witness the fastest AI in cybersecurity market growth during the forecast period due to the rising emphasis on safeguarding sensitive and confidential information.”   Active companies in cybersecurity news today include Cycurion Inc. (NASDAQ: CYCU), Cloudflare, Inc. (NYSE: NET), Palo Alto Networks® (NASDAQ: PANW), Broadcom Inc. (NASDAQ: AVGO), CrowdStrike (NASDAQ: CRWD).

EDMONTON, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Applied Pharmaceutical Innovation (API), one of Canada’s leading life sciences commercialization organizations, is proud to announce the appointment of Dr. Launa Aspeslet as its first Chief Translational Officer.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and reaffirmed its focus on the anticipated FDA decision for TNX-102 SL, a non-opioid analgesic for fibromyalgia, with a PDUFA goal date of Aug. 15. If approved, it would mark the first new drug class for fibromyalgia in more than 15 years. Tonix also highlighted progress across its pipeline, including positive Phase 1 data for TNX-1500 in kidney transplant rejection and strong preclinical results for TNX-801, a live-virus vaccine targeting mpox and smallpox. The company ended the quarter with $131.7 million in cash and cash equivalents and reported a net loss of $16.8 million on $2.4 million in product revenue.

This Campaign Offers Early Investors Up to 50% Bonus Shares to Fuel Smart Infrastructure Expansion Across the U.S.

The "AI in Logistics and Supply Chain Management Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering.

Gauzy Ltd. (NASDAQ:GAUZ) (“Gauzy” or the “Company”), a global leader of vision and light control technologies, today announced financial results for the first quarter

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced plans to restate its 2024 consolidated financial statements and Management Discussion and Analysis due to two non-cash accounting adjustments totaling approximately $32 million related to IAS 21 foreign exchange treatment. The restatement, which has no impact on the company’s cash position, operations, or financial covenants, reclassifies $11 million in unrealized foreign exchange losses and $21 million in income tax recovery. Net income for Q4 2024 will be restated from $47.6 million to $15.2 million, and basic EPS from $0.21 to $0.07. Revised documents will be filed before the company releases Q1 2025 results on May 14, with a conference call scheduled for May 15.

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net loss narrowed by $434,141 to $2.54 million. INBS added 35 new accounts, bringing its active customer base to over 450, and continued expanding internationally through partnerships and multilingual system upgrades. The company also secured its sixth U.S. patent and advanced regulatory efforts across key global markets.

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best efforts" public offering with a single healthcare focused institutional investor for the purchase and sale of 3,952,570 shares of common stock of the Company (the "Common Stock) (or common stock equivalents in lieu thereof), at a purchase price of $1.265 per share of Common Stock. The Company further agreed to issue to the investors Series F Common Stock purchase warrants to purchase up to 3,952,570 shares of Common Stock (the "Series F Warrants"). The Series F Warrants will have an exercise price of $1.14 per share, will be exercisable immediately following the date of their issuance and will expire in five years.

SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $630,000 (or a loss of $0.09 per fully diluted share) for its third fiscal quarter ended March 31, 2025 compared to a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for the third fiscal quarter ended March 31, 2025. Net loss for the quarter ended March 31, 2025 was $671,000 (or a loss of $0.10 per fully diluted share) compared to a net loss of $1,396,000 (or a loss of $0.20 per fully diluted share) for the quarter ended March 31, 2024.

Mediacom Communications today announced the company has begun launching multi-gig and symmetrical speed broadband services in the City of Cedar Rapids.

Tamboran Resources Corporation (NYSE: TBN, ASX: TBN):

COSTA MESA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- While some Americans are struggling with unmanageable debt, they are finding many ways to cope, including limiting their use of credit cards and sticking to a rigid budget. A survey from Experian found that U.S. adults describe unmanageable debt as constant stress and a choice between paying off debt and covering basic necessities.

Appointments bring traditional financial market discipline and strategic insight to Cryptex Finance's growing suite of decentralized index products.

Marketing Intelligence and Real-Time Campaign Monitoring, Powered by Snowflake, will enable joint customers to unify fragmented marketing data across sources and teams and ensure campaign compliance and performance

Ocean Capital LLC (collectively with its affiliates, “Ocean Capital” or “we”), a significant shareholder of various Puerto Rico closed-end bond funds (the “Funds”) that are managed or co-managed by UBS Asset Managers of Puerto Rico (“UBS”), today commented on the outcome of the appeal brought in the United States Court of Appeals for the First Circuit (the “Appellate Court”) by nine Funds.1

Tufin, the leader in network and cloud security policy automation, today announced the launch of Tufin Orchestration Suite (TOS) Discovery, a new solution that helps security teams ensure their network topology is always accurate and up-to-date.

OIF, where the optical networking industry’s interoperability work gets done, held its Q2 2025 Technical and Market Awareness & Education Committees Member Meeting May 5-8, 2025 in Tallinn, Estonia.

Argano, the world’s first and largest digital services consultancy focused exclusively on enabling high performance across its clients’ business operations, today announced that it has acquired Attentis Consulting (“Attentis”), a seasoned business of Salesforce consultants serving healthcare clients across the U.S. and globally. This acquisition advances the second phase of Argano's strategic growth plan, which includes the recently announced Real Dynamic and Netlogistik acquisitions.

Mary Alice Stephenson, Founder & CEO GLAM4GOOD, has joined Fast Company’s exclusive Impact Council.

Flam is already being used by 100+ global brands including Google, Samsung and Emirates who are embracing engaging media at scale. Flam-built real-time mixed reality campaigns have reached over 580 million users.

Registration for Summer Reading Contest Opens Today to Combat “Summer Slide”

WHEATON, Ill., May 13, 2025 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (Innovator), pioneer and provider of the largest lineup of Defined Outcome ETFs™, today announced the launch of the Innovator Equity Managed 100 Buffer ETF™ (BFRZ). The ETF is designed to offer investors 100% downside protection, before fees and expenses, while maintaining exposure to U.S. large-cap equities.

Winning entries to earn a share of $15,000 in prizes

The NAMA Show 2025 wrapped up with record-breaking attendance—its highest in over two decades—as more than 5,200 industry professionals gathered in Las Vegas for three days of innovation, networking, and discovery. With innovations across every segment, the show demonstrated how convenience services is evolving to meet today’s consumer needs.

XBTDirect, a high-performance crypto trading platform, has officially opened its new global headquarters in London, United Kingdom. The launch marks a major milestone in the company’s expansion strategy and reflects a firm commitment to serving institutional clients with enhanced infrastructure, deeper operational capabilities, and premium support services.

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete and 9 partial responses among 23 evaluable patients. The company plans to initiate a Phase 2 study by year-end 2025 and highlighted the potential benefits of Orphan status, including seven years of market exclusivity upon approval.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has approved ELEVIDYS (delandistrogene moxeparvovec) for the treatment of Duchenne muscular dystrophy (DMD) under the conditional and time-limited approval pathway in Japan. ELEVIDYS is approved for individuals ages 3- to less than 8-years-old, who do not have any deletions in exon 8 and/or exon 9 in the DMD gene, and who are negative for anti-AAVrh74 antibodies. This is the first global approval to include individuals younger than 4 years of age.

Strategic Acquisition Adds Highly Complementary Business

EQNX::TICKER_START (NASDAQ:CYCU),(NASDAQ:GOOG),(NASDAQ:ZS),(NASDAQ:FFIV),(NASDAQ:CYBR) EQNX::TICKER_END

SKYX Platforms (NASDAQ: SKYX), doing business as “SKYX Technologies,” announced it will host a corporate update call to review its first quarter 2025 financial results on Wednesday, May 14, at 4:30 p.m. ET. The call will feature Founder and Executive Chairman Rani Kohen, President Steve Schmidt (former CEO of Nielsen Data Corporation and President of Office Depot International), Co-CEO Lenny Sokolow, and CFO Marc Boisseau. The company is known for its disruptive advanced and smart home platform technologies and holds more than 97 issued and pending patents globally, along with a portfolio of over 60 lighting and home décor websites.

PALM BEACH, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial Intelligence (AI) in cybersecurity refers to the use of artificial intelligence technologies to improve the detection, prevention, and response to cyber threats. The AI in cybersecurity market revenue is witnessing rapid growth as organizations increasingly adopt AI-code tools to strengthen their defense mechanisms against evolving cyberattacks. A report from POLARIS MARKET RESEARCH said that: “The global AI in cybersecurity market was valued at USD 25.40 billion in 2024. It is expected to grow from USD 31.38 billion in 2025 to USD 219.53 billion by 2034, at a CAGR of 24.1% during the forecast period.” It continued: “One of the key drivers of this market is the rising complexity and frequency of cyber threats, which traditional methods struggle to address. A 2024 report by the International Telecommunication Sector revealed that 8 billion records were breached in 2023, with over 2,800 incidents reported. The average cost of a data breach has increased by 15% in the past three years, totaling approximately USD 3.3 million for small businesses in North America, further boosting the AI in cybersecurity market expansion. Additionally, AI-powered solutions analyze vast volumes of data in real time, identifying irregularities and patterns indicative of potential breaches, thus providing proactive protection. The IoT and the expansion of connected devices generate vast amounts of data and often lack robust security measures, making them vulnerable to exploitation and creating a larger attack surface for cyber threats. A November 2024 CSIS report revealed that the UK’s National Cyber Security Center (NCSC) identified a three-fold increase in cyberattacks compared to 2023. The NCSC supported 430 incidents, with 89 deemed nationally significant, and recognized China, Russia, Iran, and North Korea as key threats. Additionally, AI-powered cybersecurity solutions are crucial in this context as they enable real-time monitoring and threat detection across multiple endpoints.” Active companies in cybersecurity news today include Cycurion Inc. (NASDAQ: CYCU), Alphabet Inc. (NASDAQ: GOOG), Zscaler, Inc. (NASDAQ: ZS), F5, Inc. (NASDAQ: FFIV), CyberArk (NASDAQ: CYBR).

Collective Health, a leading employee health benefits platform with integrated member advocacy, clinical navigation, and an extensive partner ecosystem, today announced the appointments of Caroline Jessen as Chief People Officer (CPO) and Keven Sticher as Chief Information Security Officer (CISO) and VP of Engineering. These strategic hires underscore Collective Health’s ongoing investment in exceptional leadership to support its people, customers, and long-term growth.

Horace Mann Educators Corporation (NYSE:HMN) today announced its Board of Directors has authorized a new share repurchase program of up to $50 million. Under previous authorizations, through May 9, the company had repurchased a total of $130.9 million since 2011.

Kayne Anderson (the “Firm”), a leading alternative investment manager, today announced the final closing of Kayne Private Energy Income Fund III, L.P. (“KPEIF III” or the “Fund”), with $2.25 billion in total capital commitments – significantly exceeding its $1.5 billion target.

LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.

Toronto, Ontario – May 13, 2025 – TheNewswire - Hybrid Power Solutions Inc. (CSE: HPSS) (OTC: HPSIF) (FSE: E092) ("Hybrid" or the "Company") has secured a third order for its Batt Pack Pro from a leading California-based utility. This marks the utility’s first order since their January 2025 delivery for critical field operations. This repeat order highlights the utility’s trust in the product’s reliability, durability, and value, reinforcing Hybrid Power Solutions’ role as a trusted partner in energy innovation.

White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

XI’AN, China, May 13, 2025 (GLOBE NEWSWIRE) -- BON Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the natural health and personal care sectors, today announced the groundbreaking launch of its sleep health product series. Developed using the proprietary “Glucoraphanin-Myrosinase” delivery system (patent-pending), the Company intends for this product to dramatically enhance the bio-activity (the extent to which something is absorbed and utilized by the body) of glucoraphanin, a vital bio-active compound in broccoli and will be launched under the Company’s owned brand.

Falconer to Share Strategic Insights on Scaling Innovation, Securing Critical Infrastructure, and Accelerating Capital Growth in the AI Security Sector